implant

FDA

EyePoint's Yutiq production lands in the FDA's crosshairs

After hitting a snare with its top drug prospect in May, EyePoint Pharmaceuticals has run up against another spot of trouble with the FDA.

Fraiser Kansteiner Aug 27, 2024 4:07pm

Eye

Glaukos beats path to FDA after eye implant trials hit goals

Sep 13, 2022 8:45am

Eye

In a first, China approves eye implant based solely on RWD

Jun 21, 2022 11:22am